|
September 23 - 25, 2010 | Neural prosthetic devices to replace motor, sensory, and cognitive function lost by disease or trauma hold great therapeutic promise but have been widely used in people. This conference will examine how to use neural prosthetics therapeutically. More
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium revisited the 2009 outbreak and examined strategies against future outbreaks. More
Proceedings of the “Ninth Cooley's Anemia Symposium,” held at the New York Academy of Sciences. More
-
September 23 - 25, 2010
Keynote Speaker: Apostolos P. Georgopoulos (University of Minnesota Medical School)
Neural prosthetic devices to replace motor, sensory, and cognitive function lost by disease or trauma hold great therapeutic promise but have not been widely used in people. This conference will examine how to use neural prosthetics therapeutically.
Wednesday, October 6, 2010 | 8:30 AM - 7:00 PM
Chair: Franz Hefti, PhD (Avid Radiopharmaceuticals)
This conference will highlight novel and innovative therapeutic targets for Parkinson’s Disease, biomarkers for early detection and assessment of disease progression, and emerging strategies to alleviate symptoms and/or to slow disease progression.
Tuesday, October 26, 2010 | 1:00 PM - 5:00 PM
Speakers: Katerina Akassoglou (Gladstone Institute & UCSF), Andrew Miller (Emory University School of Medicine), Malú Tansey (Emory University School of Medicine), Shi Du Yan (Columbia University) and Raz Yirmiya (Hebrew University)
Breakthroughs spanning neuroscience and immunology are rare, as they do not share a common language or purpose. This symposium highlights recent discoveries in clinical depression, the stress response, Alzheimer's and multiple sclerosis.
Wednesday, June 23, 2010 | 8:15 AM - 5:30 PM
Despite vast advances in biomedical research and technology, the medical school curriculum has remained mostly static for the past half century. This goal of this conference is to highlight innovative new models for physician training motivated by advances in science and technology, and to consider how to more closely link basic science and clinical training.
Saturday, June 12, 2010 | 8:15 AM - 3:30 PM
Organizers: Linda Duffy (National Center for Complementary and Alternative Medicine, NIH), Tri Duong (Texas A&M University), Marguerite Klein (Office of Dietary Supplements), Dan Levy (FDA), Mary Ellen Sanders (Dairy and Food Culture Technologies), and Howard Young (National Cancer Institute)
This symposium will facilitate the exchange of ideas regarding labeling and substantiation of claims for probiotics and discuss ways to translate and communicate research results in a trustful way to the consumer and health professionals.
Monday, May 24, 2010 | 1:00 PM - 5:30 PM
Organizers: Doris Bucher (New York Medical College), Jennifer Henry (The New York Academy of Sciences)
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium will revisit the 2009 outbreak and examine strategies against future outbreaks.
May 19 - 21, 2010 | Spain
Keynote Speaker: J. Michael Bishop (The G.W. Hooper Research Foundation, University of California, San Francisco)
This conference will discuss advancements, challenges, and future steps in research leading to an individualized understanding of cancer and its translation into personalized clinical care.
|
-
Annals
Edited by Gregory J. del Zoppo (University of Washington School of Medicine, Seattle, Washington), Philip B. Gorelick (University of Illinois College of Medicine at Chicago, Chicago, Illinois), and Wolfgang Eisert (University of Hannover, Hannover, Germany)
The manuscripts from this Annals issue stem from a conference entitled "Innate inflammation as the common pathway of risk factors leading to transient ischemic attacks and stroke: pathophysiology and potential interventions" held at the New York Academy of Sciences on May 9-10, 2010.
Forthcoming issue
Annals
Edited by Elliott Vichinsky (Children's Hospital and Research Center, Oakland, California) and Ellis Neufeld (Harvard Medical School, Children's Hospital, Boston, Massachusetts)
Proceedings of the “Ninth Cooley's Anemia Symposium,” held at the New York Academy of Sciences.
eBriefing
Organizers: Doris Bucher (New York Medical College) and Jennifer Henry (The New York Academy of Sciences)
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium revisited the 2009 outbreak and examined strategies against future outbreaks.
eBriefing
Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation) and Sonya Dougal (The New York Academy of Sciences)
Damage to energy-producing organelles may lead to a cascade of events resulting in Alzheimer's disease. Insights into this process and the possibility of new drug targets were the topic of an Academy symposium.
eBriefing
Organizers: Ildiko Antal (Bristol-Myers Squibb), Chad E. Beyer (University of Colorado School of Medicine), Mark R. Bowlby (Merck Research Laboratories), Beth Winkelstein (University of Pennsylvania), and Jennifer Henry (The New York Academy of Sciences)
This symposium addressed clinical applications and new pain mechanisms for the treatment of chronic pain syndromes, and provided an update on the progress and barriers to developing effective preclinical models of pain, in particular fibromyalgia.
Webinar Archive
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
|
|
|